MR and optical approaches to molecular imaging

Abdominal Imaging

Volumn 30, Issue 3, 2005, Pages 342-354

  Persigehl, T ^a   Heindel, W ^a   Bremer, C ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research Muenster (IZKF Muenster)   (Germany)

Author keywords

Abdominal imaging; Amplification strategy; Contrast media; Magnetic resonance imaging; Molecular imaging; Optical imaging; Review; Smart probes

Indexed keywords

CONTRAST MEDIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FLUORESCENT DYE; GADOLINIUM; INDOCYANINE GREEN; IODINE DERIVATIVE; IRON OXIDE; LIPOCORTIN 5; LUCIFERIN; PROTEIN; QUANTUM DOT;

ACCURACY; APOPTOSIS; BINDING AFFINITY; BIOLUMINESCENCE; BLOOD VESSEL PERMEABILITY; BONE MARROW; CAMERA; CELL LABELING; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL TYPE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DRUG TARGETING; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; HEART MUSCLE; HEMATOPOIETIC STEM CELL; HUMAN; IMAGING SYSTEM; LASER; MARKER GENE; METHODOLOGY; MOLECULAR IMAGING; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL TOMOGRAPHY; PHOTON; PRIORITY JOURNAL; PROTEIN EXPRESSION; REFLECTOMETRY; SHORT SURVEY; SIGNAL NOISE RATIO; T LYMPHOCYTE; TARGET CELL;

CAPILLARY PERMEABILITY; DIGESTIVE SYSTEM NEOPLASMS; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PEPTIDE HYDROLASES; SENSITIVITY AND SPECIFICITY;

EID: 21244504653     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-004-0230-3     Document Type: Short Survey

References (103)

1. R Weissleder U Mahmood 2001 Molecular imaging Radiology 219 316 333
2. C Bremer V Ntziachristos R Weissleder 2003 Optical-based molecular imaging: contrast agents and potential medical applications Eur Radiol 13 231 243
3. RC Brasch KC Li JE Husband 2000 In vivo monitoring of tumor angiogenesis with MR imaging Acad Radiol 7 812 823
4. C Bremer M Mustafa A Bogdanov Jr 2003 Steady-state blood volume measurements in experimental tumors with different angiogenic burdens a study in mice Radiology 226 214 220
5. GA Johnson H Benveniste RD Black 1993 Histology by magnetic resonance microscopy Magn Reson Q 9 1 30
6. BR Smith GA Johnson EV Groman E Linney 1994 Magnetic resonance microscopy of mouse embryos Proc Natl Acad Sci USA 91 3530 3533
7. A Bogdanov L Matuszewski C Bremer 2002 Oligomerization of paramagnetic substrates results in signal amplification and can be used for MR imaging of molecular targets Mol Imaging 1 16 23
8. SA Wickline GM Lanza 2002 Molecular imaging, targeted therapeutics, and nanoscience J Cell Biochem 39 suppl 90 97
9. GM Lanza X Yu PM Winter 2002 Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis Circulation 106 2842 2847
10. RC Brasch A Gossmann TH Helbich 2002 Can a small-molecular gadolinium contrast agent be applied successfully with dynamic MRI to quantitatively define brain tumor microvascular responses to angiogenesis inhibition? Acad Radiol 2 suppl S326 S327
11. H Daldrup DM Shames M Wendland 1998 Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media AJR 171 941 949
12. R Brasch K Turetschek 2000 MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report Eur J Radiol 34 148 155
13. RC Brasch H Daldrup D Shames 1998 Macromolecular contrast media-enhanced MRI estimates of microvascular permeability correlate with histopathologic tumor grade Acad Radiol 1 suppl S2 S5
14. K Turetschek S Huber E Floyd 2001 MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation Radiology 218 562 569
15. TH Helbich TP Roberts MD Rollins 2002 Noninvasive assessment of wound-healing angiogenesis with contrast-enhanced MRI Acad Radiol 1 suppl S145 S147
16. TP Roberts K Turetschek A Preda 2002 Tumor microvascular changes to anti-angiogenic treatment assessed by MR contrast media of different molecular weights Acad Radiol 2 suppl S511 S513
17. K Turetschek A Preda E Floyd 2002 MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model Acad Radiol 2 suppl S519 S520
18. K Turetschek A Preda E Floyd 2003 MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model Eur J Nucl Med Mol Imaging 30 448 455
19. HE Daldrup-Link RC Brasch 2003 Macromolecular contrast agents for MR mammography: current status Eur Radiol 13 354 365
20. AR Padhani 2002 Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions J Magn Reson Imaging 16 407 422
21. AR Padhani M Neeman 2001 Challenges for imaging angiogenesis Br J Radiol 74 886 890
22. EA Schellenberger A Bogdanov Jr D Hogemann 2002 Annexin V-CLIO: a nanoparticle for detecting apoptosis by MRI Mol Imaging 1 102 107
23. HW Kang L Josephson A Petrovsky 2002 Magnetic resonance imaging of inducible E-selectin expression in human endothelial cell culture Bioconjug Chem 13 122 127
24. S Flacke S Fischer MJ Scott 2001 Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques Circulation 104 1280 1285
25. PM Winter SD Caruthers A Kassner 2003 Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging Cancer Res 63 5838 5843
26. GM Lanza DR Abendschein X Yu 2002 Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology Acad Radiol 2 suppl S330 S331
27. PM Winter SD Caruthers X Yu 2003 Improved molecular imaging contrast agent for detection of human thrombus Magn Reson Med 50 411 416
28. PM Winter AM Morawski SD Caruthers 2003 Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles Circulation 108 2270 2274
29. DA Sipkins DA Cheresh MR Kazemi 1998 Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 623 626
30. D Artemov N Mori R Ravi ZM Bhujwalla 2003 Magnetic resonance molecular imaging of the HER-2/neu receptor Cancer Res 63 2723 2727
31. D Artemov N Mori B Okollie ZM Bhujwalla 2003 MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles Magn Reson Med 49 403 408
32. AY Louie MM Huber ET Ahrens 2000 In vivo visualization of gene expression using magnetic resonance imaging Nat Biotechnol 18 321 325
33. PJ Josephson R Weissleder 2001 Magnetic nanosensors for the detection of oligonucleotide sequences Angew Chem In Ed 40 3204 3206
34. JM Perez L Josephson T O'Loughlin 2002 Magnetic relaxation switches capable of sensing molecular interactions Nat Biotechnol 20 816 820
35. JM Perez T O'Loughin FJ Simeone 2002 DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents J Am Chem Soc 124 2856 2857
36. J Grimm JM Perez L Josephson R Weissleder 2004 Novel nanosensors for rapid analysis of telomerase activity Cancer Res 64 639 643
37. MF Kircher JR Allport EE Graves 2003 In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors Cancer Res 63 6838 6846
38. A Moore PZ Sun D Cory 2002 MRI of insulitis in autoimmune diabetes Magn Reson Med 47 751 758
39. N Beckmann C Cannet M Fringeli-Tanner 2003 Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation Magn Reson Med 49 459 467
40. N Beckmann R Falk S Zurbrugg 2003 Macrophage infiltration into the rat knee detected by MRI in a model of antigen-induced arthritis Magn Reson Med 49 1047 1055
41. HE Daldrup-Link M Rudelius RA Oostendorp 2003 Targeting of hematopoietic progenitor cells with MR contrast agents Radiology 228 760 767
42. JW Bulte T Douglas B Witwer 2002 Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents Acad Radiol 2 suppl S332 S335
43. M Lewin N Carlesso CH Tung 2000 Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat Biotechnol 18 410 414
44. JM Hill AJ Dick VK Raman 2003 Serial cardiac magnetic resonance imaging of injected mesenchymal stem cells Circulation 108 1009 1014
45. JW Bulte ID Duncan JA Frank 2002 In vivo magnetic resonance tracking of magnetically labeled cells after transplantation J Cereb Blood Flow Metab 22 899 907
46. JW Bulte S Zhang P van Gelderen 1999 Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination Proc Natl Acad Sci USA 96 15256 15261
47. V Ntziachristos CH Tung C Bremer R Weissleder 2002 Fluorescence molecular tomography resolves protease activity in vivo Nat Med 8 756 760
48. V Ntziachristos C Bremer EE Graves J Ripoll R Weissleder 2002 In vivo tomographic imaging of near-infrared fluorescent probes Mol Imaging 1 82 88
49. V Ntziachristos C Bremer R Weissleder 2003 Fluorescence imaging with near-infrared light: new technological advances that enable in-vivo molecular imaging Eur Radiol 13 195 208
50. V Nztiachristos C Tung C Bremer R Weissleder 2001 Fluorescence-mediated tomography resolves protease activity in vivo Nat Med 8 757 760
51. V Ntziachristos AG Yodh M Schnall B Chance 2000 Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement Proc Natl Acad Sci USA 97 2767 2772
52. R Weissleder V Ntziachristos 2003 Shedding light onto live molecular targets Nat Med 9 123 128
53. X Gao WC Chan S Nie 2002 Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding J Biomed Opt 7 532 537
54. S Kim YT Lim EG Soltesz 2004 Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping Nat Biotechnol 22 93 97
55. YT Lim S Kim A Nakayama 2003 Selection of quantum dot wavelengths for biomedical assays and imaging Mol Imaging 2 50 64
56. X Intes J Ripoll Y Chen 2003 In vivo continuous-wave optical breast imaging enhanced with Indocyanine Green Med Phys 30 1039 1047
57. CLK Perlitz P Hauff S Wisniewski M Schirner 2002 Molecular imaging of tumors using fluorescent dyes [abstract] Mol Imaging 1 184
58. S Achilefu HN Jimenez RB Dorshow 2002 Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents J Med Chem 45 2003 2015
59. A Becker C Hessenius K Licha 2001 Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands Nat Biotechnol 9 327 331
60. A Becker C Hessenius S Bhargava 2000 Cyanine dye labeled vasoactive intestinal peptide and somatostatin analog for optical detection of gastroenteropancreatic tumors Ann NY Acad Sci 921 275 278
61. LY Moon T O'Loughlin Y Tang 2003 Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate Bioconjug Chem 14 539 545
62. EA Schellenberger A Bogdanov Jr A Petrovsky 2003 Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy Neoplasia 5 187 192
63. HW Kang R Weissleder A Bogdanov Jr 2002 Targeting of MPEG-protected polyamino acid carrier to human E-selectin in vitro Amino Acids 23 301 308
64. A Zaheer RE Lenkinski A Mahmood 2001 In vivo near-infrared fluorescence imaging of osteoblastic activity Nat Biotechnol 19 1148 1154
65. S Ke X Wen M Gurfinkel 2003 Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts Cancer Res 63 7870 7875
66. R Weissleder CH Tung U Mahmood A Bogdanov Jr 1999 In vivo imaging of tumors with protease-activated near-infrared fluorescent probes Nat Biotechnol 17 375 378
67. C Bremer S Bredow U Mahmood 2001 Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model Radiology 221 523 529
68. C Bremer CH Tung R Weissleder 2001 In vivo molecular target assessment of matrix metalloproteinase inhibition Nat Med 7 743 748
69. K Marten C Bremer K Khazaie 2002 Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice Gastroenterology 122 406 414
70. C Bremer C-H Tung A Bogdanov R Weissleder 2002 Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes Radiology 222 814 818
71. R Weissleder A Moore U Mahmood 2000 In vivo magnetic resonance imaging of transgene expression Nat Med 6 351 355
72. R Weissleder 1999 Molecular imaging: exploring the next frontier Radiology 212 609 614
73. RN Day A Periasamy F Schaufele 2001 Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus Methods 25 4 18
74. M Chalfie Y Tu G Euskirchen 1994 Green fluorescent protein as a marker for gene expression Science 263 802 805
75. M Yang E Baranov P Jiang 2000 Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases Proc Natl Acad Sci USA 97 1206 1211
76. A Moore E Marecos M Simonova 1998 Novel gliosarcoma cell line expressing green fluorescent protein: A model for quantitative assessment of angiogenesis Microvasc Res 56 145 153
77. A Moore N Sergeyev S Bredow R Weissleder 1998 A model system to quantitate tumor burden in locoregional lymph nodes during cancer spread Invasion Metastasis 18 192 197
78. W Wang JB Wyckoff VC Frohlich 2002 Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling Cancer Res 62 6278 6288
79. JW Hastings 1996 Chemistries and colors of bioluminescent reactions: a review Gene 173 5 11
80. S Bhaumik SS Gambhir 2002 Optical imaging of Renilla luciferase reporter gene expression in living mice Proc Natl Acad Sci USA 99 377 382
81. MA Funovics H Alencar HS Su 2003 Miniaturized multichannel near infrared endoscope for mouse imaging Mol Imaging 2 350 357
82. L Josephson MF Kircher U Mahmood 2002 Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes Bioconjug Chem 13 554 560
83. MF Kircher U Mahmood RS King 2003 A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation Cancer Res 63 8122 8125
84. MG Harisinghani J Barentsz PF Hahn 2003 Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2491 2499
85. U Mahmood CH Tung Y Tang R Weissleder 2002 Feasibility of in vivo multichannel optical imaging of gene expression: experimental study in mice Radiology 224 446 451
86. J Fang Y Shing D Wiederschain 2000 Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model Proc Natl Acad Sci USA 97 3884 3889
87. J Folkman 1999 Angiogenic zip code [news] Nat Biotechnol 17 749
88. DR Edwards G Murphy 1998 Cancer. Proteases-invasion and more [news] Nature 394 527 528
89. T Aparicio S Kermorgant V Dessirier 1999 Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats Carcinogenesis 20 1445 1451
90. L Herszenyi M Plebani P Carraro 1999 The role of cysteine and serine proteases in colorectal carcinoma Cancer 86 1135 1142
91. JE Koblinski M Ahram BF Sloane 2000 Unraveling the role of proteases in cancer Clin Chim Acta 291 113 135
92. K McCarthy T Maguire G McGreal 1999 High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer Int J Cancer 84 44 48
93. H Kanayama K Yokota Y Kurokawa 1998 Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer Cancer 82 1359 1366
94. B Davidson I Goldberg J Kopolovic 1999 MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma-a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization Gynecol Oncol 73 372 382
95. E Campo J Munoz R Miquel 1994 Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival Am J Pathol 145 301 309
96. MR Emmert-Buck MJ Roth Z Zhuang 1994 Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples Am J Pathol 145 1285 1290
97. A Khan M Krishna SP Baker BF Banner 1998 Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma Mod Pathol 11 704 708
98. A Khan M Krishna SP Baker 1998 Cathepsin B expression and its correlation with tumor-associated laminin and tumor progression in gastric cancer Arch Pathol Lab Med 122 172 177
99. GI Murray ME Duncan P O'Neil 1996 Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer Nat Med 2 461 462
100. H Kuniyasu LM Ellis DB Evans 1999 Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma Clin Cancer Res 5 25 33
101. M Sakakibara S Koizumi Y Saikawa 1999 Membrane-type matrix metalloproteinase-1 expression and activation of gelatinase A as prognostic markers in advanced pediatric neuroblastoma Cancer 85 231 239
102. CH Tung RE Gerszten FA Jaffer R Weissleder 2002 A novel near-infrared fluorescence sensor for detection of thrombin activation in blood Chembiochem 3 207 211
103. J Chen CH Tung U Mahmood 2002 In vivo imaging of proteolytic activity in atherosclerosis Circulation 105 2766 2771